Using the Synthesized Peptide HAYED (5) to Protect the Brain Against Iron Catalyzed Radical Attack in a Naturally Senescence Kunming Mouse Model
Zhenyou Zou,Jing Cai,Aiguo Zhong,Yong Zhou,Zengxian Wang,Zhongmin Wu,Yue Yang,Xin Li,Xiaoying Cheng,Jie Tan,Yihao Fan,Xiaotong Zhang,Yuxiang Lu,Yaping Zhou,Liu Yang,Chengliang Zhang,Qiang Zhao,Derong Fu,Qiqiong Shen,Jie Chen,Shi Bai,Lijuan Wu,Yongfeng Chen,Xin Chen,Jiaren Chen,Hongjie Zheng,Hongdian Wang,Yingjie Lou,Yarong Ding,Shiyi Shen,Ying Ye,Lifen Chen,Yukai Lin,Jue Huang,Kechun Zou,Jianxing Zhang,Baohua Bian,Chengbo Huang,Cuiping Rong,Limiao Dai,Yali Xu,Lin Cheng,Ye Chen,Yewen Luo,Shanshan Zhang,Liangxian Li
DOI: https://doi.org/10.1016/j.freeradbiomed.2018.11.014
IF: 8.101
2018-01-01
Free Radical Biology and Medicine
Abstract:Alzheimer's disease (AD) is a progressive neurodegenerative disease of the brain. It cannot be cured currently, and those suffering from AD place a great burden on their caregivers and society. AD is characterized by high levels of iron ions in the brain, which catalyze radicals that damage the neurons. Knowing that the Aβ42 peptide precipitates iron by binding iron ions at amino acid residues D1, E3, H11, H13, and H14, we synthesized a 5-repeat (HAYED) sequence peptide. By treating iron-stressed SH-SY5Y cells with it and injecting it into the cerebrospinal fluid (CSF) of naturally senescence Kunming mouse, which displaying AD-similar symptoms such as learning and memory dysfunction, neuron degeneration and high level of iron in brain, we found that HAYED (5) decreased the iron and radical levels in the cell culture medium and in the CSF. Specially, the synthesized peptide prevented cell and brain damage. Furthermore, functional magnetic resonance imaging (fMRI), Morris water maze and passive avoidance tests demonstrated that the peptide ameliorated brain blood-oxygen metabolism and slowed cognitive loss in the experimental senescence mice, and clinical and blood tests showed that HAYED (5) was innoxious to the kidney, the liver and blood and offset the AD-associated inflammation and anemia.